Keymed Biosciences (HKSE:02162) Accumulated Depreciation : HK$-196.3 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Keymed Biosciences Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Keymed Biosciences's quarterly accumulated depreciation declined from Dec. 2023 (HK$-119.0 Mil) to Jun. 2024 (HK$0.0 Mil) but then increased from Jun. 2024 (HK$0.0 Mil) to Dec. 2024 (HK$-196.3 Mil).

Keymed Biosciences's annual accumulated depreciation increased from Dec. 2022 (HK$-63.9 Mil) to Dec. 2023 (HK$-119.0 Mil) and increased from Dec. 2023 (HK$-119.0 Mil) to Dec. 2024 (HK$-196.3 Mil).

Keymed Biosciences Accumulated Depreciation Historical Data

The historical data trend for Keymed Biosciences's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Keymed Biosciences Accumulated Depreciation Chart

Keymed Biosciences Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

Get a 7-Day Free Trial

-28.47

-43.22

-63.89

-119.04

-196.29

Keymed Biosciences Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Accumulated Depreciation	Get a 7-Day Free Trial						-63.89	-	-119.04	-	-196.29

Keymed Biosciences Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Keymed Biosciences Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Keymed Biosciences's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Keymed Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Keymed Biosciences Inc (HKSE:02162) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 18 BioTown Middle Road, Building D2, Tianfu International BioTown, Chengdu, Sichuan, CHN, 610219

Website

https://www.keymedbio.com

Keymed Biosciences Inc is a biotechnology company with multiple clinical-stage assets. The company is focused on the in-house discovery and development of biological therapies that address large underserved medical needs in the autoimmune and oncology therapeutic areas. Its clinical-stage drug candidates include CM310, CM326, CM313, and CM336 among others. The company is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment. Geographically, it generates a majority of its revenue from overseas markets and the rest from Mainland China.

Executives

Chen Bo	2201 Interest of corporation controlled by you
Eagle Hero Management Limited	2101 Beneficial owner
Trident Trust Company (hk) Limited	2301 Trustee
Moonshot Holdings Limited	2101 Beneficial owner
Hh Kny Holdings Limited
Hillhouse Investment Management, Ltd.
Boyu Capital Group Holdings Ltd
Xyxy Holdings Ltd.
Tong Xiaomeng

Keymed Biosciences Headlines

No Headlines